Tavapadon as treatment for Parkinson’s disease: a systematic review, meta-analysis, and trial sequential analysis of randomized clinical trials
Background: Current Parkinson’s disease therapies are often limited by adverse events from D2/D3 receptor activation. Tavapadon, a novel selective D1/D5 partial agonist, emerges as a promising alternative for effective motor control with an improved safety profile. Objective: To perform a systematic review, meta-analys...